Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Laboratory and Clinical Medicine|July 6, 2000
Regulation of Candida albicans growth and adhesion by salivaE Ueta, T Tanida, S Doi, et al.
Cancer Letters|February 3, 1999
Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cellsK Yoneda, T Yamamoto, E Ueta, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Suppression of respiratory burst of polymorphonuclear leukocytes by azelastine hydrochloride (Azeptin)E Ueta, T Osaki, N Kawasaki, et al.
The Journal of Pharmacy and Pharmacology|September 29, 1998
Influence of twinline, an elemental diet, on the generation of nitric oxide and reactive-oxygen intermediates from mouse peritoneal macrophages and polymorphonuclear leukocytesE Ueta, K Yoneda, T Yamamoto, et al.
Cancer Letters|June 22, 1999
The inhibitory action of BOF-A2, a 5-fluorouracil derivative, on squamous cell carcinomaK Yoneda, T Yamamoto, E Ueta, et al.
Japanese Journal of Cancer Research : Gann|July 3, 1999
Manganese superoxide dismutase negatively regulates the induction of apoptosis by 5-fluorouracil, peplomycin and gamma-rays in squamous cell carcinoma cellsE Ueta, K Yoneda, T Yamamoto, et al.
International Journal of Oral and Maxillofacial Surgery|October 1, 1996
Intraosseous carcinoma arising from mandibular ameloblastoma with progressive invasion and pulmonary metastasisE Ueta, K Yoneda, A Ohno, et al.
Free Radical Research|June 1, 1995
Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycinE Ueta, T Osaki, K Yoneda, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblastsE Ueta, T Osaki, K Yoneda, et al.
Journal of Clinical Immunology|July 1, 1992
Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-gamma in oral cancer patientsK Yoneda, T Yamamoto, E Ueta, et al.
Pageof 7